This inventor holds 7 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Qiagen Gmbh, Qiagen Gmbh Max-Volmer-Strasse 4. Active years: 2001-2016.
Location History:
- Erkrath, DE (2001)
- Mettman, DE (2004)
- Mettmann, DE (2001 - 2014)
- Hann, DE (2016)
Company Filing History:
Years Active: 2001-2016
Title: The Innovative Contributions of Jie Kang
Introduction
Jie Kang is a notable inventor based in Mettmann, Germany. He has made significant contributions to the field of nucleic acid research, holding a total of 7 patents. His work focuses on developing advanced methodologies and compositions that enhance the efficacy of small interfering nucleic acids (siNAs) and nucleic acid polymerases.
Latest Patents
One of Jie Kang's latest patents is titled "Modified siNA." This invention pertains to the use of at least one abasic modification within the first 8 nucleotide positions of the 5' region of the antisense strand of a small interfering nucleic acid (siNA) molecule for reducing off-target effects. The patent provides suitable modified siNAs, compositions, methods for producing respective siNAs, and kits comprising these siNAs. Another significant patent is for "Thermostable chimeric nucleic acid polymerases and uses thereof." This patent discloses novel thermostable chimeric nucleic acid polymerases and methods for their generation and use. It demonstrates that these chimeric nucleic acid polymerases, such as DNA polymerases, can be constructed using enzymatically active domains isolated from different proteins or chemically synthesized. The chimeric polymerases possess the chemical and physical properties of their component domains, including exonuclease activity and thermostability.
Career Highlights
Jie Kang has worked with Qiagen GmbH, a leading company in the biotechnology sector. His role at Qiagen has allowed him to contribute to groundbreaking research and development in nucleic acid technologies. His expertise in this area has positioned him as a valuable asset in the field.
Collaborations
Throughout his career, Jie Kang has collaborated with notable professionals, including Peter Hahn and Andreas Missel. These collaborations have further enriched his research and innovation efforts.
Conclusion
Jie Kang's contributions to the field of nucleic acid research are significant and impactful. His innovative patents and collaborations highlight his dedication to advancing scientific knowledge and technology. His work continues to influence the development of effective nucleic acid applications.